Surface serology is an important determinant in Spiroplasma systematics. Reciprocal antigen/antibody reactions between spiroplasmas and individual antisera delineate the 38 described groups and species.
The spiroplasma deformation (DF) test is a central feature of spiroplasma systematics that examines the cell surface antigenicity of clonal isolates. Originally adopted for detecting Spiroplasma poulsonii (then a "noncultivable" agent causing sex ratio abnormalities in Drosophila willistoni), the technique was modified for general use in spiroplasma systematics (15, 16) .
The DF test has subsequently been used, in part, to define spiroplasma groups (6, 12, 17) and species (1) . There are currently 38 described serogroups (reviewed in 7; 14) , and some of the groups are further subdivided. For example, group I has eight subgroups that include five characterized species (7) . The serogroup I subgroups have 0.986-0.991 16S rDNA sequence similarity, yet distinctive serologies (5).
Horse flies or tabanids (Diptera:Tabanidae) are a rich source of spiroplasmas (2, 4, 13) . A large-scale biodiversity survey of tabanid-associated spiroplasmas began in the southeastern United States in 1987, with most spiroplasmas being isolated from female tabanids in southeast Georgia (Bulloch County). Based on DF tests, nine groups and five subgroups (of group VIII) were isolated in this initial survey.
When the study was extended to tabanid-associated spiroplasmas in Costa Rica, Ecuador and Australia, the number of putative groups increased even more rapidly than in the southeastern United States. To date, over 1,000 spiroplasma isolations have been completed from tabanid flies as part of this environmental survey.
664
French, F.E. et al.
Faced with a deluge of new isolates, the standard DF test that individually examines the reciprocal serology of each antigen/antiserum pair was impractical. Instead, a polyvalent screen (PVS) was adopted that used mixtures of antisera directed against spiroplasma strains known to occur in tabanids. The initial PVS trial screened more than 400
isolates from the southeastern United States and the Costa Rican highlands using a total of 13 antisera (all against known U.S.A. tabanid-associated strains) distributed in 6 screening cocktails ( Table 1) . As the study progressed, the number and content of the screening mixtures were modified.
For example, the screening array was expanded to 24 antisera in 12 cocktails to process isolates from the Costa Rican lowlands (Table 1) , and later it was expanded further to include 38 antisera in 12 cocktails to screen Australian and Ecuadorian isolates (Table 1) . Initially, the components of each cocktail were selected based on serological relationships. For example, one antisera cocktail (Table 1, cocktail 2) contained all group VIII strains that had low level cross-reactivity (8) . As the study progressed and novel serogroups were identified, the new antisera were included in the cocktails with the fewest number of component antisera.
This approach was dynamic and efficient, as antisera against new serogroups/strains could be added to screening cocktails as needed.
The screening cocktails were generated by combining equal volumes of each antiserum in M1D medium (10) to A.
B.
C.
10 µm 10 µ µ µ µm Table 1 . Polyvalent screen antisera cocktails for tabanid-associated spiroplasmas. The PVS rapidly revealed that most of the new isolates were matches to known serogroups. All isolates that were positive to a screening cocktail were tested in individual DF tests using each of the component antisera; the two-fold dilution series examined antisera titers of 1:20 to 1:2560.
Generally, an isolate reacting with antiserum to a described group at a concentration <1:320 was considered to be a member of that group. An isolate exhibiting no or only low levels of cross reactivity (1:20-1:40) to all antisera in the PVS was tentatively given candidate status as a new serovar.
When the original isolations were mixed cultures or when adaptation to laboratory media was required for optimal morphology (14) , additional passages and/or limiting dilution cloning (3,11) were necessary before serological placement could be achieved.
As new groups emerged, antisera to triply-cloned strains were prepared and added to the PVS and DF tests. The six Costa Rican highland serogroups were previously described (14) , but that report did not provide the detailed resolution matrix data. 2 Early passage isolates were screened with antisera mixtures; mixtures that resulted in positive reactions (>50% deformation) are indicated in parentheses. 3 Nonreactive isolates were subjected to 1-2 rounds of dilution cloning and then retested with the PVS mixtures. 4 All isolates were triply cloned and then retested with PVS mixtures. 5 One-way deformation (DF) tests were completed using individual antisera from any mixture that showed any level of reactivity in the PVS. 6 Antisera were produced for nonreactive and representative isolates; titers against antigenic homologues are indicated. 7 Strains or antisera are listed for reactions at titers >40. 8 One-way DF titers >320 allowed tentative serogroup placement; tentative isolate placement in a previously described serogroup generally served as the testing end-point. 9 Not applicable based on test procedures or prior screening results. 10 Member of a novel serogroup identified in the Costa Rican highlands (14).
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S. lineolae was not included in the original PVS screen but was tested individually against all isolates as a closely related species.
Screening for Spiroplasma
